Status: current, Defined. Date: 30-Sep 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4636995019 | Product containing remogliflozin etabonate (medicinal product) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 4636996018 | Remogliflozin etabonate-containing product | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Remogliflozin etabonate-containing product | Is a | Sodium glucose cotransporter subtype 2 inhibitor-containing product | true | Inferred relationship | Some | ||
| Remogliflozin etabonate-containing product | Is a | Carbohydrate derivative-containing product | true | Inferred relationship | Some | ||
| Remogliflozin etabonate-containing product | Has active ingredient | Remogliflozin etabonate | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Remogliflozin etabonate only product | Is a | True | Remogliflozin etabonate-containing product | Inferred relationship | Some | |
| Remogliflozin etabonate-containing product in oral dose form | Is a | True | Remogliflozin etabonate-containing product | Inferred relationship | Some |
This concept is not in any reference sets
FHIR